Golden Meditech Holdings Limited reported unaudited consolidated earnings results for the six months ended September 30, 2017. For the period, the company reported revenue from continuing operations of HKD 117,069,000 compared to HKD 121,672,000 a year ago. Loss from operations was HKD 100,156,000 compared to HKD 162,014,000 a year ago. Loss attributable to Equity shareholders of the Company was HKD 63,092,000 or 2.13 cents per basic share compared to HKD 394,437,000 or 13.30 cents per basic share a year ago. The decrease has slowed down as compared to the corresponding period last year, mainly attributable to further optmisation on the Group's revenue mix. Loss before taxation was HKD 307,367,000 against HKD 325,548,000 a year ago. Loss attributable to equity shareholders of the company from continuing operations was HKD 287,444,000 or 9.69 cents per basic share against HKD 317,154,000 or 10.69 cents per basic share a year ago. Net cash generated from operating activities was HKD 630,871,000 against HKD 64,325,000 a year ago. Payments for purchase of property, plant and equipment was HKD 46,304,000 against HKD 44,183,000 a year ago.